X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with VENUS REMEDIES - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs VENUS REMEDIES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA VENUS REMEDIES PLETHICO PHARMA/
VENUS REMEDIES
 
P/E (TTM) x -1.1 -821.4 - View Chart
P/BV x 0.0 0.2 7.0% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PLETHICO PHARMA   VENUS REMEDIES
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
VENUS REMEDIES
Mar-16
PLETHICO PHARMA/
VENUS REMEDIES
5-Yr Chart
Click to enlarge
High Rs395218 181.1%   
Low Rs3182 38.1%   
Sales per share (Unadj.) Rs604.4365.6 165.3%  
Earnings per share (Unadj.) Rs32.51.5 2,185.6%  
Cash flow per share (Unadj.) Rs51.337.9 135.4%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs473.6382.5 123.8%  
Shares outstanding (eoy) m34.0811.44 297.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.40.4 85.9%   
Avg P/E ratio x6.6101.0 6.5%  
P/CF ratio (eoy) x4.24.0 104.9%  
Price / Book Value ratio x0.50.4 114.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,2621,717 423.1%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m1,596324 492.0%   
Avg. sales/employee Rs ThNM4,100.7-  
Avg. wages/employee Rs ThNM318.0-  
Avg. net profit/employee Rs ThNM16.7-  
INCOME DATA
Net Sales Rs m20,5984,183 492.5%  
Other income Rs m38620 1,922.1%   
Total revenues Rs m20,9844,203 499.3%   
Gross profit Rs m2,818812 347.2%  
Depreciation Rs m642417 154.1%   
Interest Rs m1,593380 419.5%   
Profit before tax Rs m96935 2,759.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-13818 -764.5%   
Profit after tax Rs m1,10717 6,511.1%  
Gross profit margin %13.719.4 70.5%  
Effective tax rate %-14.351.6 -27.7%   
Net profit margin %5.40.4 1,322.2%  
BALANCE SHEET DATA
Current assets Rs m18,8772,771 681.3%   
Current liabilities Rs m11,8961,931 616.0%   
Net working cap to sales %33.920.1 168.9%  
Current ratio x1.61.4 110.6%  
Inventory Days Days36125 28.7%  
Debtors Days Days19854 368.1%  
Net fixed assets Rs m9,8615,328 185.1%   
Share capital Rs m341114 297.8%   
"Free" reserves Rs m12,3314,177 295.2%   
Net worth Rs m16,1394,376 368.8%   
Long term debt Rs m4,7061,911 246.3%   
Total assets Rs m33,1468,428 393.3%  
Interest coverage x1.61.1 147.2%   
Debt to equity ratio x0.30.4 66.8%  
Sales to assets ratio x0.60.5 125.2%   
Return on assets %8.14.7 173.0%  
Return on equity %6.90.4 1,765.6%  
Return on capital %12.36.6 186.2%  
Exports to sales %21.40-   
Imports to sales %15.220.5 74.2%   
Exports (fob) Rs m4,402NA-   
Imports (cif) Rs m3,136858 365.4%   
Fx inflow Rs m4,4020-   
Fx outflow Rs m3,184858 371.0%   
Net fx Rs m1,219-858 -142.0%   
CASH FLOW
From Operations Rs m2,437469 519.9%  
From Investments Rs m-6,26529 -21,454.5%  
From Financial Activity Rs m2,490-464 -537.2%  
Net Cashflow Rs m-1,33735 -3,875.8%  

Share Holding

Indian Promoters % 82.7 32.9 251.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 0.2 2,388.9%  
FIIs % 5.5 0.6 948.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 66.4 11.3%  
Shareholders   10,665 20,121 53.0%  
Pledged promoter(s) holding % 85.7 36.4 235.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   TORRENT PHARMA  ALKEM LABORATORIES  AJANTA PHARMA  SANOFI INDIA  ALEMBIC PHARMA  

Compare PLETHICO PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - VENUS REMEDIES COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS